Detalles de la búsqueda
1.
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Lancet
; 399(10336): 1695-1707, 2022 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35405085
2.
Safety of radiosurgery concurrent with systemic therapy (chemotherapy, targeted therapy, and/or immunotherapy) in brain metastases: a systematic review.
Cancer Metastasis Rev
; 40(1): 341-354, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33392851
3.
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.
Lancet
; 396(10260): 1422-1431, 2020 10 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002431
4.
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.
Lancet Oncol
; 21(10): 1341-1352, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002438
5.
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
Lancet Oncol
; 20(12): 1740-1749, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31629656
6.
The "Friday peak" in surgical referrals for spinal metastases: lessons not learned. A retrospective analysis of 201 consecutive cases at a tertiary center.
Acta Neurochir (Wien)
; 161(6): 1069-1076, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31037499
7.
BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol.
BMC Cancer
; 18(1): 566, 2018 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29769060
8.
Oligometastatic renal cell carcinoma: radiotherapy as a new standard of care?
Lancet Oncol
; 22(12): 1644-1645, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34856135
9.
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
Lancet Oncol
; 17(6): 747-756, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27160475
10.
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France.
BMC Cancer
; 15: 222, 2015 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-25884302
11.
Quality of life of 1276 elderly patients with prostate cancer, starting treatment with a gonadotropin-releasing hormone agonist: results of a French observational study.
Aging Male
; 17(2): 87-93, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24576298
12.
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 14(2): 149-58, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23306100
13.
Enhancing the referral process for surgical management of spinal metastases: insights from a 12-year, bi-institutional study of 533 patients.
Front Oncol
; 14: 1301305, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38352892
14.
Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07).
Eur Urol
; 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38490854
15.
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer.
Clin Transl Radiat Oncol
; 44: 100702, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38111609
16.
Radiation therapy post radical prostatectomy: who, when and why?
Curr Opin Support Palliat Care
; 17(1): 47-54, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36367534
17.
Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review.
Eur Urol Oncol
; 2023 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37640583
18.
Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline.
Radiat Oncol
; 18(1): 113, 2023 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37408055
19.
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol.
Clin Transl Radiat Oncol
; 40: 100613, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36968576
20.
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study.
Eur Urol Oncol
; 6(4): 390-398, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37059627